| HS Code | 454652 |
| Cas Number | 4326-33-6 |
| Molecular Formula | C15H21NO5 |
| Molecular Weight | 295.33 g/mol |
| Iupac Name | methyl (2S)-2-[(tert-butoxycarbonyl)amino]-3-(4-hydroxyphenyl)propanoate |
| Synonyms | Boc-Tyr-OMe; N-BOC-L-tyrosine methyl ester; tert-Butyloxycarbonyl-L-tyrosine methyl ester |
| Purity | ≥98% (HPLC) |
| Appearance | White to off-white crystalline powder |
| Melting Point | 84-86 °C |
| Storage Conditions | Store at 2-8 °C, protected from moisture |
| Solubility | Soluble in methanol, ethanol, DMF, DCM; sparingly soluble in water |
| Smiles | CC(C)(C)OC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)OC |
| Inchi | InChI=1S/C15H21NO5/c1-15(2,3)20-14(19)16-12(13(18)21-4)9-10-5-7-11(17)8-6-10/h5-8,12,17H,9H2,1-4H3,(H,16,19)/t12-/m0/s1 |
As an accredited BOC-L-tyrosine Methyl Ester factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | BOC-L-tyrosine Methyl Ester is packaged in a sealed amber glass bottle, containing 5 grams, with a tamper-evident cap and label. |
| Container Loading (20′ FCL) | BOC-L-tyrosine Methyl Ester packed in sealed drums, loaded into a 20′ FCL container with secure bracing and proper labeling. |
| Shipping | BOC-L-tyrosine Methyl Ester ships in tightly sealed, light-resistant containers under ambient conditions. Keep dry and away from heat, moisture, and direct sunlight. Standard laboratory packaging with relevant documentation and SDS is included. Not classified as hazardous for transport under normal conditions. |
| Storage | Store BOC-L-tyrosine Methyl Ester in a tightly sealed container, protected from light and moisture, in a cool, dry place. For optimal stability, refrigerate at 2–8°C or freeze at -20°C. Keep away from heat, ignition sources, and incompatible materials. Minimize repeated freeze-thaw cycles to preserve purity and activity. |
| Shelf Life | Store in a cool, dry, dark place; stable for up to 2 years under proper conditions. |
BOC-L-tyrosine methyl ester, methyl (2S)-3-(4-hydroxyphenyl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoate, C15H21NO5, 295.33 g/mol, is used as a protected tyrosine synthon in solution-phase assembly of peptide APIs when the α-amino group must remain blocked through a fragment coupling sequence and the carboxylic acid must remain masked as a methyl ester until selective saponification is required. In a representative coupling step, the compound is dissolved in dry N,N-dimethylformamide at 0–5 °C to a concentration of 0.20 M. The carboxyl component is activated with 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride at 1.05 eq and 1-hydroxybenzotriazole monohydrate at 1.05 eq; the amine component is added after a preactivation hold of 10 min. N,N-diisopropylethylamine is charged to 2.0 eq. The reaction mixture is held at 2–8 °C for 1 h, then warmed to 20–25 °C for 16 h. Conversion is monitored by reversed-phase HPLC on a C18 column with a 0.1% trifluoroacetic acid/acetonitrile gradient at 1.0 mL/min; the methyl ester peak area is typically required to fall below 2.0 area% before workup. The workup uses ethyl acetate dilution followed by sequential washes with 1 M potassium hydrogen sulfate, 5% sodium bicarbonate, and 26% sodium chloride. The organic phase is dried over sodium sulfate, filtered, and concentrated below 40 °C. Residual solvent levels are controlled under USP <467> or Ph. Eur. 2.4.24; elemental impurities are assessed according to ICH Q3D. The isolated intermediate is either carried forward directly or recrystallized from ethyl acetate/heptane to raise purity above 99.5 area%. When the downstream peptide sequence requires a free C-terminal acid, the methyl ester is cleaved with lithium hydroxide at 1.1 eq in tetrahydrofuran/water 3:1 at 0–5 °C for 45–90 min. The reaction is quenched with saturated ammonium chloride, and the resulting BOC-L-tyrosine is extracted into ethyl acetate. This transformation is sensitive to residual water in the solvent; on pilot scale, DMF moisture above 200 ppm by Karl Fischer titration is associated with incomplete activation and batch-to-batch yield variance. A 20 L jacketed glass reactor with retreat-curve impeller agitation at 150 rpm and a cooling ramp of 2 °C/min provides sufficient temperature control. The terminal products from this route are tyrosine-containing peptide fragments that are subsequently deprotected to yield peptide API intermediates; the methyl ester is not present in final drug substances.
In the preparation of endogenous opioid peptide analogs containing an N-terminal Tyr-Gly-Gly sequence, BOC-L-tyrosine methyl ester is first converted to BOC-L-tyrosine because the free carboxylic acid must be available for fragment condensation while the acid-labile BOC group continues to block the α-amine. The saponification is run with BOC-L-tyrosine methyl ester at 1.0 eq in tetrahydrofuran/methanol/water 4:2:1 at 0–5 °C. Lithium hydroxide at 1.05 eq is added portionwise, and the mixture is held for 45 min. Prolonged base contact at the α-carbon can increase D-tyrosine content in the isolated acid; therefore the reaction is quenched by acidification to pH 3.0 with cold 0.5 M hydrochloric acid and immediately extracted with methyl tert-butyl ether. The organic phase is washed with 26% sodium chloride, dried, and concentrated below 35 °C. Enantiomeric purity of BOC-L-tyrosine is checked by chiral HPLC under USP <621>; the D-enantiomer acceptance limit is typically ≤0.5 area%. BOC-L-tyrosine is then coupled to H-Gly-Gly-OMe hydrochloride using 1-[bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b]pyridinium 3-oxide hexafluorophosphate at 1.1 eq and N,N-diisopropylethylamine at 2.5 eq in N,N-dimethylformamide at 0–20 °C for 2 h. The retained BOC group prevents premature N-terminal acylation and suppresses diketopiperazine formation at the dipeptide amine stage; after complete fragment assembly, the BOC group is removed with trifluoroacetic acid/triisopropylsilane/water 95:2.5:2.5 at 5–10 °C for the first 30 min to limit tert-butylation of the tyrosine phenolic oxygen. A +56 Da byproduct is monitored by LC-MS and controlled at ≤0.15 area%. The final peptide is precipitated with cold methyl tert-butyl ether and lyophilized from 0.1 M acetic acid. Published large-scale yield data for this exact opioid fragment configuration remain limited; process transfer therefore relies on qualified laboratory demonstration batches and on-line reaction monitoring. The terminal products are N-terminal tyrosine peptide fragments used in opioid pharmacophore studies, such as Leu-enkephalin analogs, and are produced under the facility-level controlled substance handling regime applicable to the final opioid peptide in the manufacturing jurisdiction.
Impurity profiling and release testing of protected amino acid building blocks use BOC-L-tyrosine methyl ester as an external reference standard because the tyrosine chromophore provides a stable UV response at 275 nm and the compound can be baseline-resolved from BOC-L-tyrosine, L-tyrosine methyl ester hydrochloride, and BOC-D-tyrosine methyl ester on standard C18 columns. A reference stock solution is prepared in acetonitrile/water 80:20 at 0.1 mg/mL and stored in amber glass at 2–8 °C for not more than 7 days. The HPLC procedure uses a 250 × 4.6 mm C18 column with 5 μm particles, column temperature 40 °C, flow rate 1.0 mL/min, and UV detection at 220 nm for impurity quantitation with 275 nm confirmation. Method qualification follows ICH Q2(R1); linearity, repeatability, intermediate precision, and accuracy are established on the receiving instrument, and exact LOD/LOQ values are determined per instrument rather than transferred from manufacturer literature. For residual BOC-L-tyrosine methyl ester in a final peptide API, the unspecified impurity threshold is typically set at ≤0.10% under ICH Q3A when the daily dose is not more than 2 g/day. The reference material is also used for signal-to-noise ratio determination during trace-level screening of BOC-protected amino acids in incoming synthetic peptide intermediates. Laboratories performing this testing operate under ISO/IEC 17025:2017 for calibration records, reference material traceability, and method validation documentation. The terminal product in this application is not a drug substance but a qualified analytical reference material supporting release and stability testing across the protected amino acid supply chain.
BOC-L-tyrosine methyl ester is a convenient protected precursor to N-methacryloyl-L-tyrosine methyl ester, a polymerizable monomer with a pendent L-tyrosine methyl ester group. The BOC group is first removed with 4 M hydrogen chloride in dioxane at 20 °C for 2 h; the solvent is evaporated below 40 °C, and the resulting L-tyrosine methyl ester hydrochloride is triturated with cold methyl tert-butyl ether. The hydrochloride is neutralized with triethylamine at 2.0 eq in dichloromethane, cooled to −10 °C, and treated with methacryloyl chloride at 1.05 eq added over 30 min under nitrogen. The mixture is held at −10 to 0 °C for 1 h, warmed to 20 °C for 2 h, and quenched with 5% sodium bicarbonate. The organic layer is washed with 1 M hydrochloric acid and brine, dried over sodium sulfate, and concentrated below 30 °C. The monomer is isolated by column chromatography on silica gel with ethyl acetate/hexane 1:1. Polymerization is carried out by reversible addition–fragmentation chain transfer in N,N-dimethylformamide at 70 °C for 18 h using 4-cyano-4-[(dodecylsulfanylthiocarbonyl)sulfanyl]pentanoic acid and azobisisobutyronitrile at a molar ratio of monomer/chain transfer agent/initiator of 200:1:0.2. The polymerization solution is subjected to three freeze-pump-thaw cycles before heating. The polymer is precipitated in diethyl ether, redissolved in dichloromethane, and reprecipitated twice. Molecular weight distribution is determined by size-exclusion chromatography with multi-angle light scattering using N,N-dimethylformamide containing 0.05 M lithium bromide as mobile phase; the chromatography framework follows ISO 16014-3:2019. Residual unreacted monomer is quantified by HPLC at 254 nm and controlled below 1.0 wt% before any biomedical evaluation. If the resulting polymethacrylate is intended for a medical device coating, chemical characterization is conducted under ISO 10993-18 and cytotoxicity testing under ISO 10993-5. The terminal product is a polymethacrylate bearing pendent L-tyrosine methyl ester groups for surface modification and biomaterial coating studies.
Reduction of BOC-L-tyrosine methyl ester to BOC-L-tyrosinol is used in chiral oxazolidinone synthesis because the carbamate survives lithium borohydride reduction but is removed cleanly with acid before cyclization. BOC-L-tyrosine methyl ester at 1.0 eq is dissolved in dry tetrahydrofuran at 0 °C under nitrogen and treated with lithium borohydride at 2.5 eq. The mixture is warmed to 20 °C and stirred for 6 h. The reaction is quenched carefully with 1 M potassium hydrogen sulfate and extracted with ethyl acetate; the organic phase is washed with brine, dried, and concentrated to give BOC-L-tyrosinol. The BOC group is removed with 4 M hydrogen chloride in dioxane at 20 °C for 2 h; the precipitated L-tyrosinol hydrochloride is filtered and washed with cold methyl tert-butyl ether. Cyclization is performed with 1.1 eq of 1,1′-carbonyldiimidazole in dichloromethane at 0 °C. The reaction is sensitive to moisture because water hydrolyzes the imidazolide intermediate; the solvent is controlled to ≤0.05% water by Karl Fischer titration before charging. The resulting imidazole byproduct is removed by washing with 1 M hydrochloric acid. The oxazolidin-2-one ring is then N-acylated with pivaloyl chloride at 1.05 eq and triethylamine at 1.2 eq in dichloromethane at 0 °C to give (4S)-4-(4-hydroxybenzyl)-3-pivaloyloxazolidin-2-one. Enantiomeric purity is measured by chiral HPLC against USP <621>; the D-enantiomer limit is typically ≤0.5 area%. The terminal product is a chiral oxazolidinone auxiliary used in asymmetric enolate alkylation during pharmaceutical intermediate synthesis; it is not itself an API and is not carried into final drug substances without removal.
BOC-L-tyrosine methyl ester can be selectively acylated at the phenolic oxygen while the BOC and methyl ester groups remain intact, generating a protected tyrosine phenolic ester for subsequent PEG conjugation. BOC-L-tyrosine methyl ester at 1.0 eq is reacted with succinic anhydride at 1.2 eq in dichloromethane containing pyridine at 2.0 eq and 4-dimethylaminopyridine at 0.1 eq. The mixture is held at 20 °C for 24 h, then quenched with 1 M hydrochloric acid and extracted into dichloromethane. The O-succinyl intermediate is activated with N-hydroxysuccinimide at 1.2 eq and N,N′-dicyclohexylcarbodiimide at 1.2 eq in dichloromethane at 0–20 °C for 16 h; the precipitated dicyclohexylurea is removed by filtration, and the active ester is used immediately without extended storage. Methoxypolyethylene glycol amine of number-average molecular weight 2000 g/mol or 5000 g/mol is added at 0.95 eq with N,N-diisopropylethylamine at 1.1 eq in dichloromethane at 0 °C for 6 h. The conjugate is precipitated in cold diethyl ether and reprecipitated twice. Residual succinic anhydride and N-hydroxysuccinimide are quantified by HPLC and controlled below 0.5 wt% before further processing. Polyethylene glycol polydispersity is determined by size-exclusion chromatography according to a validated internal method aligned with ISO 16014-3:2019. If the material enters a biomedical testing program, cytotoxicity is evaluated under ISO 10993-5 and chemical characterization under ISO 10993-18. For the final deprotection, the methyl ester is hydrolyzed with lithium hydroxide at 1.2 eq in tetrahydrofuran/water 1:1 at 0 °C for 1 h, and the BOC group is subsequently removed with trifluoroacetic acid/triisopropylsilane/water 95:2.5:2.5 at 5–10 °C for 30 min. The terminal product is a PEGylated L-tyrosine derivative bearing a phenolic succinate linkage, used as an intermediate for solubility improvement of hydrophobic small molecules.
Competitive BOC-L-tyrosine Methyl Ester prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615365186327 or mail to admin@ascent-chem.com.
We will respond to you as soon as possible.
Tel: +8615365186327
Email: admin@ascent-chem.com
Flexible payment, competitive price, premium service - Inquire now!
BOC-L-tyrosine Methyl Ester (CAS 4326-36-7; N-α-tert-butoxycarbonyl-L-tyrosine methyl ester; molecular formula C15H21NO5; nominal molecular mass 295.33 g/mol) is supplied as a white to off-white crystalline powder. The compound carries an acid-labile tert-butoxycarbonyl group on the α-amine and a methyl ester on the C-terminal carboxyl, leaving the phenolic side chain unprotected. This substitution pattern is used in solution-phase peptide synthesis and in the preparation of C-terminal methyl ester tyrosine intermediates where the carboxyl must remain masked during N-protection manipulation.
Catalog model numbers for this material are generally differentiated only by fill size—10 g, 25 g, 100 g, 500 g, and 1 kg—and by packaging configuration rather than by chemical grade. A peptide synthesis grade designation indicates that the release panel includes HPLC purity, specific optical rotation, water content by Karl Fischer titration, residual solvent analysis, and chiral impurity control. The material is not intended for direct therapeutic use; it is a chemical intermediate subject to downstream qualification according to the user’s process.
Release protocols for BOC-L-tyrosine methyl ester are built around compendial analytical methods. HPLC purity is measured by reversed-phase C18 separation with UV detection at 220 nm; a typical acceptance limit is ≥98.0% area. The monoisotopic mass is 295.142 Da, and positive-ion electrospray ionization shows [M+H]+ at 296.149 Da and [M+Na]+ at 318.131 Da. Specific optical rotation is release-controlled by polarimetry at the sodium D-line, with typical lot values falling at [α]D20 = -7.0° ± 1.0° (c = 1, CH3OH). Karl Fischer water limit is ≤0.5% w/w per USP <921> or Ph. Eur. 2.5.12. Residual solvents are quantified by headspace gas chromatography against USP <467>; common controls are methanol ≤1000 ppm and dichloromethane ≤600 ppm. Melting range is 93–98°C by capillary method. Enantiomeric impurity, where the D-tyrosine derivative is separated on a chiral stationary phase, is controlled to ≤0.5% area.
The HPLC method uses a C18 column, 150 mm × 4.6 mm, 5 µm particle size, with mobile phase A consisting of 0.1% TFA in water and mobile phase B consisting of 0.1% TFA in acetonitrile. Gradient elution from 20% B to 90% B over 20 min separates BOC-L-tyrosine methyl ester from the free amine and from more polar process impurities. UV detection at 220 nm monitors the tyrosine aryl chromophore. Residual solvent analysis uses a DB-624 column, 30 m × 0.32 mm, 1.8 µm film, with headspace equilibration at 80°C for 30 min. Method quantification limits are typically 50 ppm for methanol and 100 ppm for dichloromethane.
| Parameter | Specification | Method |
|---|---|---|
| Appearance | White to off-white crystalline powder | Visual inspection |
| HPLC purity | ≥98.0% area at 220 nm | RP-HPLC, C18 |
| Specific optical rotation | [α]D20 = -7.0° ± 1.0° (c = 1, CH3OH) | Ph. Eur. 2.2.7 |
| Melting range | 93–98°C | Capillary |
| Water content | ≤0.5% w/w | KF, USP <921> |
| Residual solvent | MeOH ≤1000 ppm; DCM ≤600 ppm | HS-GC, USP <467> |
| Enantiomeric impurity | D-Tyr derivative ≤0.5% area | Chiral HPLC |
| Storage | 2–8°C, desiccated | — |
In solution-phase assembly, BOC-L-tyrosine methyl ester is used as a C-terminal blocked tyrosine source. The Boc group is removed before coupling by acidolysis with 20–30% TFA in dichloromethane at 0–25°C for 1–2 h, or with 4 M HCl in dioxane to precipitate the HCl salt. The methyl ester remains intact under these conditions when water is excluded; therefore anhydrous TFA or HCl/dioxane is preferred. After deprotection, the amine salt is neutralized with N-methylmorpholine or diisopropylethylamine in an ice-jacketed vessel at -5°C to 5°C and coupled immediately with a carboxyl-activated peptide fragment. Carbodiimide reagents such as DIC/HOBt or EDC/HOBt in DMF or DCM are used at 0–25°C; preactivation of 1-hydroxybenzotriazole esters reduces racemization at the tyrosine α-carbon because the N-protected urethane suppresses oxazolone formation relative to free amine conditions.
During acidolytic deprotection, the tert-butyl cation generated from the Boc group can alkylate the unprotected tyrosine phenol. To suppress this, 2–5% triisopropylsilane or 5–10% anisole is added to the TFA/DCM cleavage cocktail. The resulting H-Tyr-OMe is isolated as the TFA salt and used immediately. Failure to include a scavenger results in tert-butylated tyrosine impurities detectable by RP-HPLC at relative retention times of approximately 1.1–1.3 relative to the main product.
On a production-scale line, a glass-lined reactor fitted with a high-efficiency condenser and nitrogen sweep is charged with the Boc-protected building block. TFA is added below liquid surface with stirring, and the exotherm is controlled below 20°C. After deprotection, neutralization is conducted under a nitrogen blanket, and the resulting H-Tyr-OMe is transferred through a jacketed PTFE-lined hose to the coupling reactor to avoid moisture uptake. In campaigns producing 1–5 kg of oligopeptide intermediate, solution clarity is maintained by filtering through a 0.45 µm polypropylene cartridge before acylation. Coupling progression is monitored by RP-HPLC at 220 nm, with a target residual free amine below 2.0% area before the next acylation or wash cycle. Published kinetic data for this specific configuration is limited; therefore, for non-routine solvent systems, stability-indicating HPLC is performed at pre-determined time points to assess methyl ester hydrolysis and epimerization.
In a typical synthesis of BOC-L-tyrosine methyl ester, L-tyrosine methyl ester is acylated with di-tert-butyl dicarbonate in the presence of triethylamine or sodium bicarbonate in aqueous tetrahydrofuran. The reaction is cooled to 0–5°C to reduce racemization, and the product is extracted into ethyl acetate, washed with 1 M citric acid, saturated sodium bicarbonate, and brine, then dried over sodium sulfate. Crystallization from ethyl acetate/heptane or methyl tert-butyl ether/heptane gives a white solid with typical yields of 85–92% before recrystallization. Identity is confirmed by 1H NMR and 13C NMR; characteristic signals include a tert-butyl singlet near 1.42 ppm and a methyl ester singlet near 3.75 ppm in CDCl3, with the Boc carbonyl near 155.0 ppm and ester carbonyl near 171.5 ppm in 13C NMR. FTIR typically shows ester carbonyl absorption near 1740 cm-1, carbamate carbonyl near 1685 cm-1, and phenolic O–H stretch near 3300 cm-1.
Compared with BOC-L-tyrosine, the methyl ester form has materially different solubility and reactivity. BOC-L-tyrosine is a free acid that requires separate carboxyl activation, whereas the methyl ester is already masked at the C-terminus and therefore avoids mixed anhydride side reactions during N-deprotection. DCM and ethyl acetate solubility are higher for the methyl ester than for the free acid, which supports homogeneous coupling in low-polarity solvents and simplifies aqueous workup. The methyl ester also avoids diketopiperazine formation during dipeptide cyclization because the C-terminal carboxyl is not available for intramolecular aminolysis under mildly basic neutralization. This difference is important when preparing tyrosine-containing dipeptide fragments by solution-phase methods.
The methyl ester group can be removed later by saponification with LiOH or NaOH in aqueous tetrahydrofuran, but saponification is pH- and temperature-dependent. In neutral anhydrous DMF at 25°C, methyl ester loss is typically below 2% over 24 h; in aqueous alkali above pH 10, hydrolysis proceeds rapidly. For this reason, the compound is not held in aqueous alkaline media, and neutralization of HCl or TFA salts is performed immediately before coupling. The free phenol of tyrosine is normally not protected in standard coupling; however, if a downstream sequence requires prolonged reaction at temperatures above 50°C or exposure to strongly nucleophilic bases, temporary protection of the phenol as a tert-butyl ether or silyl ether should be evaluated by stability-indicating HPLC.
Compared with the ethyl ester analogue, the methyl ester of BOC-L-tyrosine has a lower molar mass and typically higher crystallinity. Saponification to the free carboxylic acid proceeds more readily in 0.5 M LiOH in THF/water 3:1 at 0°C. The ethyl ester may be selected when the ester is retained through a later synthetic stage because it can reduce volatility loss during solvent evaporation. Published kinetic data for the specific saponification of BOC-L-tyrosine methyl ester in all solvent systems is limited; a stability-indicating HPLC check is standard before scaling any hydrolysis step.
Desiccated storage at 2–8°C is recommended. The bulk solid should be kept in amber glass or fluoropolymer-lined aluminum foil under argon or nitrogen. When relative humidity exceeds 60%, handling should occur under dry nitrogen, and the material should be pre-dried in a vacuum desiccator over phosphorus pentoxide at room temperature for 12 h if water uptake is suspected. Adsorbed moisture does not immediately hydrolyze the methyl ester in the solid state, but it may reduce the quality of the subsequent acidolytic deprotection by generating aqueous acid microenvironments that promote ester cleavage. Avoid storage with open containers of concentrated hydrochloric acid because HCl vapor can cleave the Boc group on the powder surface.
BOC-L-tyrosine methyl ester is incompatible with strong oxidizing agents, strong reducing agents such as LiAlH4, and strong aqueous acids or bases. The Boc group is removed by TFA or HCl/dioxane, not by piperidine or morpholine, which distinguishes it from Fmoc derivatives. The methyl ester is reduced by hydride reagents to the corresponding alcohol, and the carbamate is reduced or cleaved under forcing hydride conditions. The product is for research and development use; no USP or EP monograph exists specifically for this intermediate, so release is governed by the manufacturer’s internal specifications and the user’s qualified analytical methods.
Differences from Fmoc-L-tyrosine methyl ester are defined by the orthogonal protecting group. Fmoc is base-labile and is removed with 20% piperidine in DMF in 5–20 min, while Boc is acid-labile. A synthetic route using Boc-Tyr-OMe can be carried through basic aqueous washes that would deprotect an Fmoc amine. Conversely, a route using Fmoc-Tyr-OMe can tolerate acidic conditions that would remove Boc. Cbz-L-tyrosine methyl ester is removed by catalytic hydrogenation over palladium on carbon at 1–4 atm H2 and 20–25°C, or by HBr/AcOH; this is less compatible with substrates containing reducible groups. H-L-Tyr-OMe hydrochloride lacks an N-protecting group and must be neutralized before use; its DCM solubility is low without an added base, and direct acylation may be accompanied by higher epimerization risk than the Boc-protected derivative.
| Derivative | N-removal reagent | Typical removal conditions | DCM solubility | Route compatibility |
|---|---|---|---|---|
| BOC-L-tyrosine methyl ester | TFA/DCM or HCl/dioxane | 20–30% TFA, 0–25°C, 1–2 h | High | Stable to bases and hydrogenation |
| BOC-L-tyrosine | TFA/DCM | Same as above | Moderate | Free carboxylic acid requires activation |
| Fmoc-L-tyrosine methyl ester | Piperidine/DMF | 20%, 5–20 min | High | Stable to acids; labile to secondary amines |
| Cbz-L-tyrosine methyl ester | H2/Pd-C or HBr/AcOH | 1–4 atm H2, 20–25°C | High | Avoid reducible substrates |
| H-L-Tyr-OMe hydrochloride | No N-protection | — | Low without base | Direct coupling after neutralization |
The unprotected phenolic hydroxyl of BOC-L-tyrosine methyl ester remains compatible with carbodiimide-mediated coupling and does not require protection for standard acylation at 0–25°C. The product is generally not combined with amine-based condensation additives in the absence of a carboxyl component, because such mixtures can promote N-acyl transfer or accelerate decomposition of activated esters. When the title material is converted to H-Tyr-OMe hydrochloride, immediate coupling is recommended; isolated amine salts stored beyond 24 h at room temperature may show increased moisture uptake and should be re-analyzed by HPLC before use.
The material is less suited to solid-phase peptide synthesis as a resin-loaded monomer because the C-terminal methyl ester is not reactive with aminomethyl or hydroxymethyl resin handles. In solution-phase fragment assembly, however, this ester masking allows selective N-deprotection and coupling without premature C-terminal activation. The absence of a free carboxyl also avoids charge formation that can complicate phase transfer in dichloromethane/water systems. These features differentiate BOC-L-tyrosine methyl ester from both the free acid and the unprotected methyl ester hydrochloride, and account for its selection in stepwise peptide chain extension where C-terminal retention is required until a specific deprotection point.
When the methyl ester and Boc group are both present, aqueous workup must avoid pH above 9 and strong acid above 1 M unless intentional deprotection is desired. The phenolic hydroxyl can form phenolate under basic conditions, increasing aqueous solubility and causing slight red coloration in strongly alkaline solution. Acidic washes must be brief because the Boc group is progressively cleaved in aqueous TFA or concentrated HCl. These operational boundaries are incorporated into standard batch records as pH controls and hold-time limits. If the product is exposed to a non-validated solvent mixture or heated above 40°C during drying, HPLC purity and water content should be rechecked before release for a subsequent coupling step.